Voluson SWIFT; Voluson SWIFT+

GE Medical Systems Ultrasound & Primary Care Diagnostic, LLC · K230346 · 2023-06-20

Voluson SWIFT; Voluson SWIFT+ is an AI-enabled medical device from GE Medical Systems Ultrasound & Primary Care Diagnostic, LLC, listed by FDA (510(k), K230346) with a decision date of 2023-06-20. Review panel: Radiology.

FDA submission numberK230346
Pathway510(k)
CompanyGE Medical Systems Ultrasound & Primary Care Diagnostic, LLC
Review panel (specialty)Radiology
FDA decision date2023-06-20
DecisionSubstantially Equivalent
Product codeIYN
ClassificationSystem, Imaging, Pulsed Doppler, Ultrasonic
Device class2
Regulation number892.1550
Review time (calendar days)132
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.